← Back to catalogue

CHROMID® CPS® Elite agar/Columbia CNA agar + 5% sheep blood (CPSE/CNA)

FDA UDI

Class I (US FDA UDI)

by Biomerieux , Inc.

Identity

Trade Name
CHROMID® CPS® Elite agar/Columbia CNA agar + 5% sheep blood (CPSE/CNA) FDA UDI
Generic Name
Multiple formulation agar culture medium IVD FDA UDI
Device Name
This product consists of two culture media, dispensed into one Petri dish containing separate compartments. It is intended for use with urine specimens FDA UDI
Model / Reference
CHROMID® CPS® Elite agar/Columbia CNA agar + 5% sheep blood (CPSE/CNA) FDA UDI
Description
This product consists of two culture media, dispensed into one Petri dish containing separate compartments. It is intended for use with urine specimens FDA UDI

Identifiers

Primary DI / UDI-DI
03573026600426 FDA UDI
FDA Product Code
JXA FDA UDI
GMDN Term
Multiple formulation agar culture medium IVD FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.2660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple formulation agar culture medium IVD

CHROMID® CPS® Elite agar/Columbia CNA agar + 5% sheep blood (CPSE/CNA) by Biomerieux , Inc. — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Multiple formulation agar culture medium IVD.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Biomerieux , Inc.

Sources (1)

  • FDA UDI f2aec207-bdab-4aa2-9de4-48d76e00dcaf 34 fields · synced May 30, 2026